A real-world study of adverse event profiles associated with the four key components of antibody–drug conjugates based on the FAERS database
BackgroundAntibody–drug conjugates (ADCs) exhibit structurally driven and highly heterogeneous toxicities, yet most pharmacovigilance studies remain drug-centered and lack systematic component-level evaluation. This study provides a comprehensive real-world safety assessment of FDA-approved ADCs usi...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2026-02-01
|
| シリーズ: | Frontiers in Pharmacology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1702195/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
